10-Q: NRC Health Reports Q2 2026 Results, Net Loss Widens

NRC Health filed its Form 10-Q for the quarter ended June 30, 2026, reporting a net loss of $3.3 million on increased revenue, with significant rises in operating expenses driven by stock-based compensation.

Summary

• NRC Health reported a net loss of $3.3 million for the three months ended June 30, 2026, compared to a net loss of $0.1 million in the same period of 2025. Revenue increased by 4% to $35.4 million.
• For the six months ended June 30, 2026, the company reported a net loss of $0.06 million, a significant decrease from a net income of $5.7 million in the prior year's period, while revenue grew 4% to $70.2 million.
• Operating expenses increased substantially, particularly selling, general, and administrative (SG&A) expenses, which rose 29% for the quarter and 29% for the six-month period, largely due to higher stock-based compensation.
• Total recurring contract value (TRCV) increased by 11% to $151.9 million as of June 30, 2026, indicating future revenue potential.
• The company had $3.3 million in cash and cash equivalents as of June 30, 2026, with available borrowing capacity under its credit facilities.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the reported net loss and increased operating expenses, despite revenue growth. The significant increase in stock-based compensation and executive transition costs are key concerns.

Positives

• Revenue increased by 4% to $35.4 million for the three months ended June 30, 2026, and by 4% to $70.2 million for the six months ended June 30, 2026.
• Total recurring contract value (TRCV) grew by 11% to $151.9 million as of June 30, 2026, suggesting future revenue growth.
• The company maintained compliance with its financial covenants under its credit agreement.
• Cash provided by operating activities increased by 56% to $8.6 million for the six months ended June 30, 2026, compared to the prior year period.

Negatives

• The company reported a net loss of $3.3 million for the three months ended June 30, 2026, compared to a net loss of $0.1 million in the prior year period.
• For the six months ended June 30, 2026, the company reported a net loss of $0.06 million, a significant decrease from a net income of $5.7 million in the prior year period.
• Selling, general, and administrative (SG&A) expenses increased by 29% to $22.9 million for the three months ended June 30, 2026, and by 29% to $36.4 million for the six months ended June 30, 2026.
• Stock-based compensation expense significantly increased, contributing to the rise in SG&A expenses, particularly due to amendments to executive equity awards.
• Operating income swung to a loss of $3.2 million for the three months ended June 30, 2026, from an income of $1.6 million in the prior year period.
• The company's total shareholders' equity decreased from $14.0 million at December 31, 2025, to $6.5 million at June 30, 2026.

Risks

• The possibility of non-renewal of customer service contracts, reductions in services purchased or prices, and failure to retain key customers.
• The company's ability to compete in highly competitive markets with new entrants and subject to consolidation, and the possibility of increased price pressure and expenses.
• The possibility that the company's solutions and technology do not perform as expected.
• The likelihood that a pandemic, global conflicts, or tariffs will adversely affect operations, sales, earnings, financial condition, and liquidity.
• The effects of an economic downturn and the impact of consolidation in the healthcare industry.
• The impact of federal healthcare and budget legislation, executive orders, cost-saving measures, and other regulatory changes.
• The possibility that intellectual property and proprietary information technology could be copied or independently developed by competitors.
• The possibility for failures or deficiencies in the company's information technology platform and the risk of cyber-attacks or security breaches.

Future Outlook

The company views Total Recurring Contract Value (TRCV) as a leading indicator of future revenue trends. While TRCV has grown, the company's financial performance in the reported periods shows a net loss, impacted by increased operating expenses. The company believes its existing liquidity sources will be sufficient to meet projected capital and debt maturity needs.

Management Comments

• "Our ability to measure what matters most and systematically capture, analyze, and deliver insights based on self-reported information from patients, families, and consumers is critical in todays healthcare market."
• "We believe access to, analysis of, and acting on our extensive individual-driven information is increasingly valuable as healthcare providers need to better understand and engage the people they serve to create long-term relationships, build loyalty, and improve processes."
• "We do not expect similar amendments [to executive equity awards] to be recurring events. Accordingly, the increase in stock-based compensation expense in the reported period is not necessarily indicative of such expense in future periods."

Industry Context

StockSavvy.ai notes that NRC Health operates in the healthcare technology sector, focusing on subscription-based services for understanding patient and consumer needs. The reported increase in TRCV aligns with industry trends towards data-driven insights and long-term customer relationships. However, the company's net loss and increased operating expenses, particularly stock-based compensation, are significant headwinds in a competitive market.

Comparison to Industry Standards

• The company's revenue growth of 4% for the six-month period is modest compared to some high-growth SaaS companies in adjacent sectors, but may be in line with mature healthcare IT providers.
• The significant increase in SG&A expenses, driven by stock-based compensation, is a concern. Industry benchmarks for SaaS companies often show SG&A as a percentage of revenue, and a sharp increase without corresponding revenue acceleration can signal efficiency issues.
• The reported net loss and negative earnings per share are contrary to the profitability expected from established companies in the healthcare IT space, many of which are profitable.
• The company's focus on recurring revenue through subscription services is a standard and positive model within the SaaS industry, aiming for predictable revenue streams.

Legal Proceedings

• From time to time, the company is involved in claims and litigation arising in the normal course of business. Management assesses the probability of loss and recognizes a liability when probable and estimable.

Stakeholder Impact

• Shareholders: The net loss and increased expenses may negatively impact shareholder value. The stock repurchase program could provide some support.
• Employees: Increased stock-based compensation suggests a focus on executive retention and incentives. Potential for restructuring costs impacting some employees.
• Customers: Continued focus on subscription services and customer relationships aims to maintain and grow the customer base.
• Creditors: The company's compliance with debt covenants and available borrowing capacity are relevant to creditors.

Next Steps

• The company will continue to focus on its Human Understanding strategy to improve operations for healthcare organizations.
• The company will monitor and manage its liquidity sources, including cash on hand and borrowing capacity, to meet future needs.
• The Board of Directors will continue to consider dividend declarations on a quarterly basis.
• The company will continue to evaluate recent accounting pronouncements for potential impact.

Key Dates

Recommendation

The company shows revenue growth and an increasing TRCV, indicating future potential. However, the significant net loss, increased operating expenses (especially stock-based compensation), and negative EPS for the period are concerning. The current financial performance suggests a 'hold' rating until there is a clear path to profitability and improved operational efficiency.

Keywords

Healthcare Technology, Subscription Services, Customer Engagement, Patient Experience, Employee Engagement, Financial Performance, Stock-Based Compensation, Recurring Revenue